RankAlpha logo
Back to Rankings

TVTX

Travere TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-08-05
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
TVTX vs peer average
32/100
TVTX vs. peer average (F vs. D)
Grade spread
A 1 · C 2 · D 2 · F 4
Graded peers loaded
Coverage
9 graded
90% of tracked

Peer overview

TARS is the first available peer comparator.

Tarsus is a same-cap biotech/commercial launch comparator rather than a direct kidney-disease peer; useful for event-driven commercial-execution sentiment, but weak for indication-specific valuation read-through.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerTARSTarsus
TVTX
Travere Therapeutics
TARS
Tarsus
Grade
F
D
Momentum
94
17
Value
49
41
Sentiment
20
65
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs TARS

TVTX / TARS
Grade Position
Below peers
TVTX vs. peer average (F vs. D)
32/100
Momentum
94
TVTX
Value
49
TVTX
Sentiment
20
TARS

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs TVTX
1
TARS
TARS
D
40/100
-1
2
CNTA
CNTA
-
-
-
3
ORKA
Oruka Therapeutics Inc Common
F
20/100
Even
4
DFTX
Definium Therapeutics Inc Common
F
20/100
Even
5
AMRX
Amneal Pharmaceuticals Inc Class A Common
A
100/100
-4
TARS is the first peer returned for this comparison set.